Vaccination of adults with asthma and COPD

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 1, 2011, Pages 25-31

  Pesek, R ^a   Lockey, R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

asthma; chronic obstructive pulmonary disease; influenza; pneumococcus; vaccines

Indexed keywords

CORTICOSTEROID; DIPHTHERIA PERTUSSIS TETANUS VACCINE; FLULAVAL; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; PREDNISOLONE; PREDNISONE; SINGLE STRANDED RNA; UNCLASSIFIED DRUG; VARICELLA ZOSTER VACCINE;

ADULT; ASTHMA; BACTERIAL COLONIZATION; BORDETELLA PERTUSSIS; CHICKENPOX; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE TRANSMISSION; DRUG EFFECT; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HERPES ZOSTER; HIGH RISK PATIENT; HUMAN; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; PEAK EXPIRATORY FLOW; PERTUSSIS; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TREATMENT CONTRAINDICATION; VACCINATION; VIRUS TRANSMISSION;

ADULT; AGED; AGED, 80 AND OVER; ASTHMA; BACTERIAL VACCINES; HERPES ZOSTER; HUMANS; INFLUENZA, HUMAN; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK; VACCINATION; VIRAL VACCINES; WHOOPING COUGH;

EID: 78650011516     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02462.x     Document Type: Review

References (80)

1. Deen JL, Mink CA, Cherry JD, Christenson PD, Pineda EF, Lewis K, et al. Household contact study of Bordetella pertussis infections. Clin Infect Dis 1995; 21: 1211-1219.
2. Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, Cianfrini C, Jennings CE, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004; 23: 985-989.
3. Kumar A, Grayson MH,. The role of viruses in the development and exacerbation of atopic disease. Ann Allergy Asthma Immunol 2009; 103: 181-187.
4. Nicholson KG, Kent J, Ireland DC,. Respiratory viruses and exacerbations of asthma in adults. Br Med J 1993; 307: 982-986.
5. Atmar RL, Guy E, Guntupalli KK, Zimmerman JL, Bandi VD, et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med 1998; 158: 2453-2459.
6. De Serres G, Lampron N, La Forge J, Rouleau I, Bourbeau J, Weiss K, et al. Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations. J Clin Virol 2009; 46: 129-133.
7. Juhn YJ, Kita H, Yawn BP, Boyce TG, Yoo KH, McGree ME, et al. Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol 2008; 122: 719-723.
8. De Serres G, Shadmani R, Duval B, Boulianne N, Dery P, Douville-Fradet M, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000; 182: 174-179.
9. CDC. Novel H1N1 flu: background on the situation. Available at:http://www.cdc.gov/h1n1flu/background.html.
10. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2010 northern/southern hemispheres influenza season. Available at:http://www.who.int/csr/disease/influenza/ vaccinerecommendations/en/index.html.
11. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179-186. (Pubitemid 36068705)
12. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292: 1333-1340.
13. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2008; 57: 1-60.
14. Griffin MR, Coffey CS, Neuzil KM, Mitchel EF Jr, Wright PF, Edwards KM,. Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease. Arch Intern Med 2002; 162: 1229-1236.
15. Yap FH, Ho PL, Lam KF, Chan PK, Cheng YH, Peiris JS,. Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza season in Hong Kong. J Med Virol 2004; 73: 617-623.
16. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, et al. Community Study of role of viral infections in exacerbations of asthma in 9-11 year old children. Br Med J 1995; 310: 1225-1229.
17. Miller EK, Griffin MR, Edwards KM, Weinberg GA, Szilagyi PG, Staat MA, et al. Influenza burden for children with asthma. Pediatrics 2008; 121: 1-8.
18. Wang CS, Wang ST, Lai CT, Lin LJ, Chou P,. Impact of influenza vaccination on major cause-specific mortality. Vaccine 2007; 25: 1196-1203.
19. Nikol KL, Wuorenma J, Von Sternberg T,. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998; 158: 1769-1776.
20. Nikol KL, Baken L, Nelson A,. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999; 130: 397-403.
21. Poole PJ, Chacko E, Wood-Baker RW, Cates CJ,. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; CD002733.
22. Hak E, Hoes AW, Grobbee DE, Lammers JW, Van Essen GA, Van Loon AM, et al. Conventional influenza vaccination is not associated with complications in working-age patients with asthma or chronic obstructive pulmonary disease. Am J Epidemiol 2003; 157: 692-700.
23. Cates CJ, Jefferson TO, Bara AI, Rowe BH,. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev 2004: CD000364.
24. Kramarz P, Destefano F, Gargiullo PM, Chen RT, Lieu TA, Davis RL, et al. Does influenza vaccination prevent asthma exacerbations in children? J Pediatr 2001; 138: 306-310.
25. Christy C, Aligne CA, Auinger P, Pulcino T, Weitzman M,. Effectiveness of influenza vaccine for the prevention of asthma exacerbations. Arch Dis Child 2004; 89: 734-735.
26. Bueving HJ, Thomas S, Van Der Wouden JC,. Is influenza vaccination in asthma helpful? Curr Opin Allergy Clin Immunol 2005; 5: 65-70.
27. Tata LJ, West J, Harrison T, Farrington P, Smith C, Hubbard R,. Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax 2003; 58: 835-839.
28. American Lung Association Asthma Clinical Research Centers. The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med 2001; 345: 1529-1536.
29. Fleming DM, Crovari P, Wahn U, Kemola T, Schlesinger Y, Langussis A, et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 2006; 25: 860-869.
30. Monto AS, Ohmit SE, Petrie JG, Johnson E, Truscon R, Teich E, et al. Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med 2009; 361: 1260-1267.
31. Posey WC, Nelson HS, Brancy B, Pearlman DS,. The effects of acute corticosteroid therapy for asthma on serum immunoglobulin levels. J Allergy Clin Immunol 1978; 62: 340.
32. Hamilos DL, Young RM, Peter JB, Agopian MS, Ikle DN, Barka N,. Hypogammaglobulinemia in asthmatic patients. Ann Allergy 1992; 68: 472-481.
33. Kawano T, Matsuse H, Obase Y, Kondo Y, Machida I, Tomari S, et al. Hypogammaglobulinemia in steroid-dependent asthmatics correlates with the daily dose of oral prednisolone. Int Arch Allergy Immunol 2002; 128: 240-243.
34. Levy AL, Waldmann TA,. The effect of hydrocortisone on immunoglobulin metabolism. J Clin Invest 1970; 49: 1679-1684.
35. Hanania NA, Sockrider M, Casto M, Holbrook JT, Tonascia J, Wise R, et al. Immune response to influenza vaccination in children and adults with asthma: effects of corticosteroid therapy. J Allergy Clin Immunol 2004; 113: 717-724.
36. Fairchok MP, Trementozzi DP, Carter PS, Regnery HL, Carter ER,. Effect of prednisone on response to influenza virus vaccine in asthmatic children. Arch Pediatr Adolesc Med 1998; 152: 1191-1195.
37. Park CL, Frank AL, Sullivan M, Jindal P, Baxter BD,. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Pediatrics 1996; 98: 196-200.
38. Haber P, Sejvar J, Mikaeloff Y, DeStefano F,. Vaccines and Guillain-Barre syndrome. Drug Saf 2009; 32: 309-323.
39. Guarino M, Casmiro M, D'Alessandro R,. Campylobacter jejuni infection and Guillain-Barre syndrome: a case control study. Neuroepidemiology 1998; 17: 296-302.
40. Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, et al. Guillain-Barre syndrome following influenza vaccination. JAMA 2004; 292: 2478-2481.
41. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ,. Guillain-Barre syndrome following vaccination in the National Influenza Vaccination Program, United States, 1976-1977. Am J Epidemiol 1979; 110: 105-123.
42. Souayah H, Nasar A, Suri MF, Qureshi AI,. Guillain-Barre syndrome after vaccination in United States. A report from the CDC/FDA Vaccine Adverse Reporting System. Vaccine 2007; 25: 5253-5255.
43. Souayah N, Nasar A, Suri MF, Qureshi AI,. Guillain-Barre syndrome after vaccination in the United States: data from the CDC/FDA Vaccine Adverse Reporting System (1990-2005). J Clin Neuromuscul Dis 2009; 11: 1-6.
44. Stowe J, Andrews N, Wise L, Miller E,. Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenza like illness using the United Kingdom General Practice Research Database. Am J Epidemiol 2009; 169: 382-388.
45. Hughes RA, Charlton J, Latinovic R, Gulliford MC,. No association between immunization and Guillain-Barre syndrome in the United Kingdom, 1992 to 2000. Arch Intern Med 2006; 166: 1301-1304.
46. Tam CC, O'Brien SJ, Petersen I, Islam A, Hayward A, Rodriques LC,. Guillain-Barre syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS ONE 2007; 2: e344.
47. CDC. Safety of influenza A (H1N1) 2009 monovalent vaccines, United States. MMWR Morb Mortal Wkly Rep, 2009; 58: 1351-1356.
48. James JM, Zeiger RS, Lester MR, Fasano MB, Gern JE, Mansfield LE, et al. Safe administration of influenza vaccine to patients with egg allergy. J Pediatr 1998; 133: 624-628.
49. Chung EY, Huang L, Scheider L,. Safety of Influenza vaccine administration in egg-allergic patients. Pediatrics 2010; 125: e1024-e1030.
50. Hass H, Morris JF, Samson S, Kilbourn JP, Kim PJ,. Bacterial flora of the respiratory tract in chronic bronchitis: comparison of transtracheal, fiberoptic, and oropharyngeal sampling methods. Am Rev Respir Dis 1977; 116: 41-47.
51. Sethi S, Evans N, Grant BJ, Murphy TF,. New Strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347: 465-471. (Pubitemid 34879333)
52. Kraft M,. The role of bacterial infections in asthma. Clin Chest Med 2000; 21: 301-313.
53. Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 2005; 352: 2082-2090.
54. Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB, Bonnelykke K, et al. Childhood asthma after bacterial colonization of the airways in neonates. N Engl J Med 2007; 357: 1487-1495.
55. Jung JA, Kita H, Yawn BP, Boyce TG, Yoo KH, McGree ME, et al. Increased risk of serious pneumococcal disease in patients with atopic conditions other than asthma. J Allergy Clin Immunol 2010; 125: 217-221.
56. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep, 1997; 46: 1-24.
57. Dransfield MT, Nahm MH, Han MK, Harden S, Criner GJ, Martinez FJ, et al. Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180: 499-505.
58. Vila-Corcoles A, Ochoa-Gondar O, Guzman JA, Rodriguez-Blanco T, Salsench E, Fuentes CM, et al. Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older. BMC Infect Dis 2010; 10: 73.
59. Lee TA, Weaver FM, Weiss KB,. Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma. J Gen Intern Med 2007; 22: 62-67.
60. Ansaldi F, Turello V, Lai P, Bastone G, De Luca S, Rosselli R, et al. Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study. J Int Med Res 2005; 33: 490-500.
61. Moberly SA, Holden J, Tatham DP, Andrews RM,. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008: CD000402.
62. Granger RH, Walters J, Poole PJ, Lasserson TJ, Mangtani P, Cates CJ, et al. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006: CD001390.
63. Huss A, Scott P, Stuck AE, Trotter C, Egger M,. Efficacy of pneumococcal vaccination in adults: a meta-analysis. Can Med Assoc J 2009; 180: 48-58.
64. Sumitani M, Tochino Y, Kamimori T, Fujiwara H, Fujikawa T,. Additive inoculation of influenza vaccine and 23-valent pneumococcal polysaccharide vaccine to prevent lower respiratory tract infections in chronic respiratory disease patients. Intern Med 2008; 47: 1189-1197.
65. Furumoto A, Ohkusa Y, Chen M, Kawakami K, Masaki H, Sueyasu Y, et al. Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease. Vaccine 2008; 26: 4284-4289.
66. Sheikh A, Alves B, Dhami S,. Pneumococcal vaccine for asthma. Cochrane Database Syst Rev 2002: CD002165.
67. Steentoft J, Konradsen HB, Hilskov J, Gislason G, Andersen JR,. Response to pneumococcal vaccine in chronic obstructive lung disease-the effects of ongoing, systemic steroid treatment. Vaccine 2006; 24: 1408-1412.
68. De Roux A, Schmidt N, Rose M, Zielen S, Pletz M, Lode H,. Immunogenicity of the pneumococcal polysaccharide vaccine in COPD patients. The effects of systemic steroids. Respir Med 2004; 98: 1187-1194.
69. Lahood N, Emerson SS, Kumar P, Sorensen RU,. Antibody levels and response to pneumococcal vaccine in steroid-dependent asthma. Ann Allergy 1993; 70: 289-294.
70. Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: recommendations of the Advisory Committee on Vaccine Practices. MMWR Recomm Rep 2006; 55: 1-17.
71. Cherry JD,. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis 1999; 28: S112-S117.
72. CDC. Transmission of pertussis from adult to infant-Michigan, 1993. MMWR Morb Mortal Wkly Rep 1995; 44: 74-76.
73. Nelson JD,. The changing epidemiology of pertussis in young adults. The role of adults as reservoirs of infection. Am J Dis Child 1978; 132: 371-373.
74. Von Konig W, Halperin S, Riffelmann M, Guiso N,. Pertussis of adults and infants. Lancet Infect Dis 2002; 2: 744-750.
75. Harju TH, Leinonen M, Nokso-Koivisto J, Korhonen T, Raty R, He Q, et al. Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma. Thorax 2006; 61: 579-584.
76. Bonhoeffer J, Bar G, Riffelmann M, Soler M, Heininger U,. The role of Bordetella infections in patients with acute exacerbations of chronic bronchitis. Infection 2005; 33: 13-17.
77. FDA clinical briefing document for tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed (Tdap, ADACEL™), Aventis Pasteur, Limited. Rockville, MD. US Department of Health and Human Services, Food and Drug Administration (FDA); 2005. Available at http://www.fda.gov/ohrms/ dockets/ac/05/briefing/2005-4097B1-4a.pdf.
78. Ennis DP, Cassidy JP, Mahon BP,. Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a Murine model. Clin Diagn Lab Immunol 2005; 12: 409-417.
79. Ennis DP, Cassidy JP, Mahon BP,. Whole-cell pertussis vaccine protects against Bordetella pertussis exacerbation of allergic asthma. Immunol Lett 2005; 97: 91-100.
80. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271-2284.